Skip to main content
Premium Trial:

Request an Annual Quote

NIH Wants Gene Function Studies to Support Undiagnosed Diseases Program

NEW YORK (GenomeWeb News) – The US National Institutes of Health wants to provide further support for efforts to understand the function of genes that may be involved in certain diseases, particularly genes that have recently been identified through its Undiagnosed Diseases Program, the agency said this week. It plans to award up to $150,000 to supplement such efforts next year.

Since it launched in 2008 with the mission of studying the "most puzzling medical cases" that are referred to the NIH Clinical Center, the UDP has received around 6,300 inquiries that have led to the evaluation of 450 patients and the diagnosis of around 100 patients.

NIH sees the combination of genomic and genetic analyses with gene function studies as a way to revolutionize how undiagnosed diseases are studied by uncovering links between gene defects, patient phenotypes, and diseases.

So far, the UDP has discovered and described two unknown diseases and identified 15 genes that were not previously associated with human disease.

This administrative supplement program aims to support efforts to understand what these genes do in the context of physiology and pathophysiology of the diseases of interest, whether and how genetic variation affects gene expression and function, and whether and how particular genes and their specific variants are involved in disease pathogenesis. Priority will be given to studies seeking to provide new mechanistic insight into gene function that is relevant to the specific disease under study.

Because gene function studies often require interdisciplinary investigations, NIH is encouraging applications from teams from across multiple disciplines, such as genetics, informatics, molecular and cellular biology, biochemistry, pharmacology, and others.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.